Navigation Links
Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
Date:4/30/2009

ncertainties and other factors not under the Company's control and which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of REOLYSIN as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009
2. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
3. Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
4. Oncolytics Biotech(R) Inc. Collaborators Present Reovirus Research at Replicating Oncolytic Virus Meeting
5. Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
6. Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
7. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
8. Oncolytics Biotech(R) Inc. Reports Highlights and Financial Results for 2008
9. Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America
10. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
11. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The DNA Spectrum Ancestry Map ... of history, migration, and culture. , Throughout his ... history stories stemming from Europe. His father passionately referred ... and 8mm home movies painted an elaborate picture of ... Steve ordered a test from DNA Spectrum to expand ...
(Date:7/22/2014)... CAMBRIDGE, Massachusetts e SHENZHEN ... Solutions Co., LTD, (BGI Tech), una filiale di BGI, ... il lancio mondiale di un nuovo servizio di sequenziamento ... settore di Complete Genomics. Complete Genomics, ... fornire tecnologie di sequenziamento proprietarie con il 99.999% di ...
(Date:7/22/2014)... Ore. , July 22, 2014  Semler ... an emerging medical risk assessment company that develops ... patients and evaluating chronic diseases, today announced that ... before the open of U.S. financial markets on July ... Semler will host a conference call at 11 a.m. ...
(Date:7/22/2014)... New Jersey , 22. Juli 2014 /PRNewswire/ ... die Life-Sciences-Industrie, hat die Ernennung von Marcus Bergler ... bekanntgegeben. Herr Bergler hat die europäischen kommerziellen Aktivitäten ... unterstützt. Bevor er sich Qforma anschloss, war er ... Cegedim Customer Information, als Vertriebsteam-Leiter Deutschland bei IMS ...
Breaking Biology Technology:DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 2DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 3DNA Test from DNA Spectrum Shows Heritage Like a Map of the Past 4BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2Semler to Report Second Quarter 2014 Financial Results and Host Conference Call on July 25, 2014 2Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2
... - GeneNews Limited (TSX: GEN),a company focused ... the early detection of diseases and personalized ... collecting patient samples,for clinical validation studies of ... June 2006, GeneNews presented training set results ...
... /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX, FSE: "HBP") today ... by way of private placement, of a total ... gross proceeds totaling CDN$16,867,200.,Proceeds from the placement will ... Company,s research and development initiatives., The Company ...
... and Product Development Company to Establish Presence in ... UK/European Market from the Midlands, ... announced that Nebraska based GeneSeek has chosen the British,Midlands as ... be setting up their new base of operations in BioCity,Nottingham, ...
Cached Biology Technology:GeneNews initiates patient sample accrual for validation studies of colon cancer blood test 2GeneNews initiates patient sample accrual for validation studies of colon cancer blood test 3Helix BioPharma announces $16.9 million private placement of common shares 2GeneSeek Selects the British Midlands as Base for New UK/European Operations 2GeneSeek Selects the British Midlands as Base for New UK/European Operations 3
(Date:7/21/2014)... Millar , a professor of entomology and ... at the University of California, Riverside, has been ... International Society of Chemical Ecology ( ISCE ). , ... is the society,s highest honor. It is awarded ... chemical ecology, the study of chemicals that mediate interactions ...
(Date:7/21/2014)... has issued a high health risk warning for Yellowknife ... region due to forest fires. Currently 160 wildfires ... plans for evacuation since these fires are endangering people ... area recently comes with mixed results. The rains ... to start others. , This year the Northern Territories ...
(Date:7/21/2014)... A University of California, San Diego School of Medicine-led ... not recognize the potentially serious health consequences of childhood ... in helping their child reach a healthy weight. , ... of the Academy of Nutrition and Dietetics . , ... and physical activity behaviors," said lead author Kyung Rhee, ...
Breaking Biology News(10 mins):UC Riverside entomologist receives international honor for chemical ecology contributions 2Parents rank their obese children as 'very healthy' 2
... that a group of genetic rogue elements, produced by DNA ... and bowel cancer. Their research, funded by Cancer Research UK, ... The researchers, led by Dr Cristina Tufarelli, in the School ... of these faulty genetic elements known as chimeric transcripts ...
... discussion and debate emanating from the COP15 United ... expected, the majority of climate change discussion surrounding ... - regulations to restrict carbon emissions, exploration of ... Paradise Regained: The Regreening of Earth (Springer, $27.50) ...
... from the Institute for Animal Health, Pirbright, UK Met ... Meteorological Department, are working together on an early-warning system ... disease, reveals a study published today in Weather ... information to anticipate when disease carrying midges are likely ...
Cached Biology News:'Junk DNA' could spotlight breast and bowel cancer 2Global warming and other environmental dangers may be solved by unlikely source -- space technology 2Scientists create early-warning system to defend rare Jersey cows from continental disease 2
... Adhesive seal tabs • Reusable, ... can be quickly assembled and disassembled for ... specimens of any thickness with up to ... three chambers per slide. Minimize specimen handling, ...
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
...
... assays, all EIA/RIA plates are manufactured from ... optical clarity and low background absorption. In ... Certified Surface Chemistry Programme, which guaarantees protein ... specifications. Linkage: This CLS number is a ...
Biology Products: